GSK Plc (GSK)
57.82
-1.36
(-2.31%)
USD |
NYSE |
Apr 15, 16:00
57.83
+0.02
(+0.03%)
After-Hours: 20:00
GSK Research and Development Expense (Annual) : 8.171B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AstraZeneca PLC | 13.84B |
| Biodexa Pharmaceuticals Plc | 5.026M |
| Novavax, Inc. | 336.82M |
| BioNTech SE | 2.376B |
| Moderna, Inc. | 2.917B |